glp 1 type 2 diabetes Clinical Focus on GLP-1 Agonists in Mellitus Novel GLP-1–Based Medications for Type

Williams said she lost 34 pounds in about a year

Living with hemophilia means balancing many aspects of daily health, from managing bleeding risks to being mindful of possible medication interactions

Within 48 hours, multiple Indian companies launched cheaper versions

Zealand Pharma's agreement with Roche to jointly develop and commercialise an experimental amylin-based weight-loss treatment will create a strong obesity trea

It's a prescription drug that treats type 2 diabetes in adults.

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide).